CLINICAL_TRIALS ClinicalTrials.gov record update

A First in Human, Phase 1 Safety Study in Two Parts to Determine the Safety, Tolerability and Anti-cancer Immune-modulatory Effects of MRx0518 in Patients With Solid Tumour Awaiting Surgical Removal of the Tumour.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03934827
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:02.190993+00:00
Published At: 2022-08-11T00:00:00+00:00
Record Updated At: 2022-08-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Melanoma", "Breast Cancer", "Uterine Cancer", "Ovarian Cancer", "Prostate Cancer", "Urethral Cancer", "Bladder Cancer", "Renal Cancer", "Lung Cancer", "Head and Neck Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-08-11"
protocolSection.identificationModule.nctId: "NCT03934827"
protocolSection.identificationModule.officialTitle: "A First in Human, Phase 1 Safety Study in Two Parts to Determine the Safety, Tolerability and Anti-cancer Immune-modulatory Effects of MRx0518 in Patients With Solid Tumour Awaiting Surgical Removal of the Tumour."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.